Measure | B | SE B | β | p | sr2 |
---|---|---|---|---|---|
a) ECR-anxiety T2-T1 predicting QIDS at post-treatment | |||||
 Step 1 | |||||
  Constant | −.89 | 2.41 |  | .71 |  |
  QIDS pre-treatment | .56 | .16 | .39 | .001 | .39 |
 Step 2 | |||||
  Constant | .58 | 2.30 |  | .80 |  |
  QIDS pre-treatment | .50 | .15 | .35 | .002 | .35 |
  ECR-anxiety T2-T1 | .15 | .05 | .35 | .002 | .35 |
b) ECR-anxiety T2-T1 predicting EUROHIS at post-treatment | |||||
 Step 1 | |||||
  Constant | 12.89 | 2.75 |  | <.001 |  |
  EUROHIS pre-treatment | .61 | .13 | .51 | <.001 | .51 |
 Step 2 | |||||
  Constant | 13.65 | 2.55 |  | <.001 |  |
  EUROHIS pre-treatment | .54 | .12 | .45 | <.001 | .45 |
  ECR-anxiety T2-T1 | −.14 | .04 | −.35 | .001 | −.35 |
c) ECR-avoidance T2-T1 predicting QIDS at post-treatment | |||||
 Step 1 | |||||
  Constant | −.89 | 2.41 |  | .71 |  |
  QIDS pre-treatment | .56 | .16 | .39 | .001 | .39 |
 Step 2 | |||||
  Constant | .88 | 2.19 |  | .69 |  |
  QIDS pre-treatment | .48 | .15 | .34 | .002 | .34 |
  ECR-avoidance T2-T1 | .18 | .04 | .43 | <.001 | .43 |
d) ECR-avoidance T2-T1 predicting EUROHIS at post-treatment | |||||
 Step 1 | |||||
  Constant | 12.89 | 2.75 |  | <.001 |  |
  EUROHIS pre-treatment | .61 | .13 | .51 | <.001 | .51 |
 Step 2 | |||||
  Constant | 12.00 | 2.41 |  | <.001 |  |
  EUROHIS pre-treatment | .62 | .11 | .52 | <.001 | .52 |
  ECR-avoidance T2-T1 | −.17 | .04 | −.43 | <.001 | −.43 |